BAC

Bank of America Corporation

60
Fundamentals72/ 100
Valuation55/ 100
Upside potential71/ 100
Risk potential10/ 100

BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.

CEPO

Cantor Equity Partners I, Inc. Class A Ordinary Shares

There isn't enough reported data to score CEPO yet.

BAC Fundamentals

MetricStatus
Healthy
Strong
N/A
N/A

BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.

CEPO Fundamentals

MetricStatus
Unavailable
Weak
N/A
N/A

CEPO's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like CEPO.

BAC PE Valuation

CHEAPFAIREXPENSIVE5.6x11x17x22x
CHEAPFAIREXPENSIVE5.6x11x17x22x
LevelPEPriceVs current
Cheap9.4x$39.50-22%
Forward10x$50.51—
Current12x$50.51—
Fair13x$53.81+6.5%
Expensive15x$62.23+23%

Historical ranges are pointers, not guarantees.

BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.

CEPO PE Valuation

CEPO has no meaningful PE right now: it lost money over the past year.

BAC Forward outlook

MetricOutlook
Improving
Growth
Growth
Strongly improving
Limited
Moderate

Analysts expect earnings and revenue growth for BAC, with profitability improving.

CEPO Forward outlook

There aren't enough analyst estimates for CEPO to show an outlook.

BAC Risk to reward

ScenarioChangePrice
Upside+25%$63.36
Downside-10%$45.36

Calculated from the latest close: $50.51 on Nov 12.

There is not enough scenario data to compare BAC and CEPO's risk to reward.

CEPO Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $10.81 on Nov 12.

There is not enough scenario data to compare BAC and CEPO's risk to reward.

BAC Earnings Per Share

Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
QuarterTTM EPSYoY
Forward$4.92+17%
Q3 2026$4.19+14%
Q2 2026$4.34+27%
Q1 2026$4.02+20%
Q4 2025$3.81+19%
Q3 2025$3.66+33%
Q2 2025$3.41+20%
Q1 2025$3.35+16%
Q4 2024$3.21+4.2%

BAC has the edge over CEPO on earnings quality, reporting a profit while its opponent remains loss making.

CEPO Earnings Per Share

Q3 2024: $-0.01Q4 2024: $-0.01Q1 2025: $0.04Q2 2025: $0.11Q3 2025: $0.16Q4 2025: $-0.26Q1 2026: $-0.46Q2 2026: $-0.27
Q3 2024: $-0.01Q4 2024: $-0.01Q1 2025: $0.04Q2 2025: $0.11Q3 2025: $0.16Q4 2025: $-0.26Q1 2026: $-0.46Q2 2026: $-0.27
QuarterTTM EPSYoY
Q2 2026-$0.27-345%
Q1 2026-$0.46-1250%
Q4 2025-$0.26-$0.25
Q3 2025$0.16+$0.17

CEPO has swung to a loss: it lost $0.27 per share over the past year, after a profit the year before.

BAC Quarterly Revenue

Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
QuarterRevenueYoY
Q3 2026$30B+6.7%
Q2 2026$31.6B+19%
Q1 2026$30.3B+11%
Q4 2025$31.2B+23%
Q3 2025$28.1B+11%
Q2 2025$26.5B+4.3%
Q1 2025$27.4B+6%
Q4 2024$25.3B+15%

BAC has the edge over CEPO on sales, with more consistent year-over-year improvement.

CEPO Quarterly Revenue

Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0

CEPO's revenue is shrinking: $0 last quarter.

BAC Free Cash Flow

Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
QuarterFree cash flowYoY
Q3 2026-$6.5B-114%
Q2 2026$29B+$38.2B
Q1 2026$41.8B+$44B
Q4 2025-$22.9B-189%
Q3 2025$46.9B+$84.2B
Q2 2025-$9.1B-150%
Q1 2025-$2.2B+$13.4B
Q4 2024$25.9B-21%

BAC has the edge over CEPO on cash flow, with more consistent year-over-year improvement.

CEPO Free Cash Flow

Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: −$84,580Q4 2024: −$49,660Q1 2025: $52,579Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: −$84,580Q4 2024: −$49,660Q1 2025: $52,579Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
QuarterFree cash flowYoY
Q2 2026$0$0
Q1 2026$0-100%
Q4 2025$0+$49.7K
Q3 2025$0+$84.6K
Q2 2025$0$0
Q1 2025$52.6K+$52.6K
Q4 2024-$49.7K-$49.7K

CEPO's free cash flow was $0 over the past year, against −$81,661 the year before. Free cash flow isn't a meaningful measure for financial services companies like CEPO.

BAC Total Shares

Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
PeriodChange %Net change
Quarterly-1%-72M shares
1 year-5.3%-405M shares
3 years-11%-854M shares
5 years-15%-1.3B shares
Available history-24%-2.2B shares

BAC has the edge over CEPO on shareholder dilution, with a more favorable share count trend.

CEPO Total Shares

Q4 2023: 26MQ1 2024: 26MQ2 2024: 26MQ3 2024: 26MQ4 2024: 26MQ1 2025: 26MQ2 2025: 26MQ3 2025: 26MQ4 2025: 26MQ1 2026: 26MQ2 2026: 26M
Q4 2023: 26MQ1 2024: 26MQ2 2024: 26MQ3 2024: 26MQ4 2024: 26MQ1 2025: 26MQ2 2025: 26MQ3 2025: 26MQ4 2025: 26MQ1 2026: 26MQ2 2026: 26M
PeriodChange %Net change
Quarterly0%--
1 year0%--

CEPO has 26M diluted shares, about the same as a year ago.

BAC Net Leverage

Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
QuarterNet LeverageStatus
Q3 20266.4xHigh
Q2 20266.7xHigh
Q1 20267.1xHigh
Q4 20257.7xHigh
Q3 20258.3xHigh
Q2 20258.8xHigh
Q1 20258.6xHigh
Q4 20249.0xHigh

BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.

CEPO Net Leverage

BAC Weekly Momentum

MetricValueStatus
RSI37.1Neutral
Stochastic4.9Oversold

BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).

CEPO Weekly Momentum

MetricValueStatus
RSI66.0Neutral
Stochastic81.8Overbought

CEPO's weekly RSI is 66 (neutral) and its Stochastic is 82 (overbought).

BAC PE vs Financial Services Sector

MetricBACSector medianRelative
PE12x13x7.5% below
PE %406323 pts below

BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.

CEPO PE vs Financial Services Sector

MetricCEPOSector medianRelative
PEN/A13x—

CEPO has no meaningful PE right now: it lost money over the past year.

BAC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$52.13% below
20 week MA$57.813% below
50 week MA$54.77.7% below
100 week MA$50.50% below
200 week MA$42.519% above

CEPO has stronger trend alignment. BAC is above 1 of 5 weekly averages versus CEPO above 3 of 3.

CEPO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$10.80.3% above
20 week MA$10.70.7% above
50 week MA$10.62% above

CEPO is in an uptrend: it's above all three of its weekly moving averages, and 2% above its 50-week average.

BAC Yearly ROI

YearStart priceEnd priceROI
2020$35.4$30.0-15%
2021$30.0$44.4+48%
2022$44.4$32.5-27%
2023$32.5$33.7+3.7%
2024$33.7$44.3+32%
2025$44.3$56.2+27%
2026 YTD$56.2$50.5-10%

BAC has finished higher in four of the last six years. It's down 10% so far in 2026.

CEPO Yearly ROI

YearStart priceEnd priceROI
2025$10.1$10.4+3.8%
2026 YTD$10.4$10.8+3.6%

CEPO has the edge over BAC on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key